Si-Yu Wu
Overview
Explore the profile of Si-Yu Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu M, Gu D, Wang R, Wang K, Wu S, Han S, et al.
J Asian Nat Prod Res
. 2024 Nov;
:1-10.
PMID: 39570283
ABATRACTTwo new compounds, namely, isorhamnenin-3--neohesperidin-6''-linoleic acid ester () and isorhamnenin-3--neohesperidin-6''-palmitate (), along with 17 known compounds, were isolated from Pollen Typhae Carbonisatus (PTC). Their structures were elucidated on the basis...
2.
Wu H, Gong Y, Ling Y, Wu S, Ji P, Zhao Q, et al.
Med
. 2024 Nov;
6(3):100535.
PMID: 39520982
Background: Although the prognosis of triple-negative breast cancer (TNBC) has significantly improved in the era of immunotherapy, many TNBC patients are resistant to therapies, and their disease progresses rapidly. Deciphering...
3.
Jia H, Zhang S, Chen Y, Qiao Y, Yao Y, Zhang X, et al.
Int J Gynecol Pathol
. 2024 Oct;
43(6):595-604.
PMID: 39418587
The purpose of this study is to investigate the characteristics and significance of tertiary lymphoid structures (TLSs) in endometrial cancer (EC) based on molecular subtypes. A total of 220 patients...
4.
Wu S, Jie H, Wu D, Qin S, Tang X, Wang R, et al.
Nat Prod Res
. 2024 Jan;
:1-6.
PMID: 38226496
Two new sesquiterpene glycosides, 8,12,15-trihydroxycopacamphan-15---D-glucopyranoside () and dendrobiumane C-11---D-glucopyranoside (), along with three known terpenoids () were isolated from the aerial stems of . Their structures were elucidated based on...
5.
Wu S, Li J, Zhang Y, Wu H, Mo M, Hu N, et al.
Br J Surg
. 2023 May;
110(10):1264-1266.
PMID: 37252942
No abstract available.
6.
Wu S, Li J, Wang Y, Jin K, Yang B, Li J, et al.
Int J Surg
. 2023 May;
109(7):1863-1870.
PMID: 37132193
Background: Targeted axillary dissection (TAD) includes biopsy of clipped lymph node and sentinel lymph nodes. However, clinical evidence regarding clinical feasibility and oncological safety of non-radioactive TAD in a real-world...
7.
Wu S, Li J, Wu H, Shao Z, Liu G, Hu N
Br J Surg
. 2022 Aug;
109(12):1194-1197.
PMID: 36018290
No abstract available.
8.
Wu H, Lu Y, Li J, Wu S, Chen X, Liu G
Front Oncol
. 2022 Feb;
11:791995.
PMID: 35198434
Introduction: Locoregional recurrent breast cancer indicates poor prognosis. No solid prediction model is available to predict prognosis and guide clinical management. Prior local treatment or systemic treatment remains controversial. Methods:...
9.
Yang F, Wu S, Mo M, Xiao Q, Yang X, Liu Y, et al.
Transl Cancer Res
. 2022 Feb;
9(1):155-165.
PMID: 35117169
Background: To investigate ipsilateral breast tumor recurrence (IBTR) in patients who have undergone breast-conserving surgery (BCS) after neoadjuvant systematic therapy (NST). Method: Three hundred and twenty-one patients undergoing BCS after...
10.
Wu S, Xiao Y, Wei J, Xu X, Jin X, Hu X, et al.
J Immunother Cancer
. 2021 Jul;
9(7).
PMID: 34321275
Background: Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and lacks definite treatment targets. Tumor immune microenvironment (TIME) heterogeneity has a profound impact on the immunotherapy...